Red White & Bloom Brands Exercises Option to Acquire PharmaCo (Michigan)
July 27, 2020
Red White & Bloom Brands Inc. announced it has exercised its option to acquire 100% of PharmaCo, Inc. through its wholly owned subsidiary MichiCann Medical Inc., issuing up to 37 million units as consideration subject to regulatory approvals. The move gives Red White & Bloom a direct entry and a significant retail footprint in the Michigan cannabis market as part of the company's multi-state expansion strategy.
- Buyers
- Red White & Bloom Brands Inc., MichiCann Medical Inc.
- Targets
- PharmaCo, Inc.
- Industry
- Retail
- Location
- Michigan, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
PharmaCann Acquires LivWell Enlightened Health
February 28, 2022
Retail
PharmaCann Inc. has completed its previously announced acquisition of LivWell Holdings, Inc., combining the two vertically integrated cannabis operators into a platform with over 50 dispensaries and 10 cultivation/production facilities across eight U.S. states. The transaction expands PharmaCann's presence into Colorado and Michigan; LivWell founder and CEO John Lord will join the PharmaCann board.
-
Curaleaf Acquires Bloom Dispensaries
December 28, 2021
Consumer Products
Curaleaf Holdings, Inc. agreed to acquire Bloom Dispensaries, a vertically integrated single-state cannabis operator in Arizona, in an all-cash transaction valued at approximately US$211 million. The deal adds four retail dispensaries (Phoenix, Tucson, Peoria, Sedona) plus ~63,500 sq. ft. of adjacent cultivation and processing space in north Phoenix; Curaleaf will pay $51 million cash at close and the remainder via three promissory notes, and Bloom generated estimated 2021 revenue of ~$66 million with EBITDA margins above 40%.
-
MediPharm Labs Corp. Acquires VIVO Cannabis Inc.
April 1, 2023
Pharmaceuticals
Effective April 1, 2023, MediPharm Labs Corp. completed an all-equity arrangement to acquire all outstanding shares of VIVO Cannabis Inc., making VIVO a wholly-owned subsidiary. Under the arrangement, former VIVO shareholders received 0.2910 MediPharm common shares per VIVO share and MediPharm issued approximately 107,930,964 shares as consideration; VIVO shares are expected to be delisted from the Toronto Stock Exchange.
-
Nutrabolt Expands Strategic Investment in Bloom Nutrition
September 9, 2025
Consumer Products
Nutrabolt has made a new, significant investment in Bloom Nutrition, expanding a strategic partnership that began with a minority stake in January 2024. The investment strengthens Nutrabolt's consumer wellness portfolio and supports Bloom's continued product and distribution expansion while Bloom's founders remain in control of the brand.
-
BR Brands Acquires Mary's Brands (Mary's Medicinals)
August 21, 2019
Consumer Products
BR Brands, a cannabis CPG platform, completed the acquisition of the remaining capitalization and control of Mary's Brands (maker of Mary's Medicinals) concurrent with the first close of BR Brands' Series A, which was backed by strategic capital partner Rose Capital. The deal expands BR Brands' portfolio and manufacturing capabilities as part of a buy-and-build strategy to scale premium cannabis CPG brands across multiple U.S. markets.
-
Neon Bloom, Inc. Acquires Bazelet Health Systems, Inc.
March 18, 2021
Biotechnology
Neon Bloom, Inc. (OTC: NBCO) has completed an all-stock acquisition of 100% of Bazelet Health Systems, Inc., issuing 120,000,000 Neon Bloom common shares. The deal brings Bazelet’s plant science, CRISPR-based genome engineering capabilities and accredited cannabis education business under Neon Bloom to accelerate research, commercialization and expansion in the legal cannabis/hemp and life‑sciences markets.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.